But the FDA also says officials cannot definitively rule out that "a small risk may exist” and that they’ll continue to look into reports regarding more than a dozen drugs.
Regeneron Pharmaceuticals Inc. will soon start testing its antibody drugs in combination with Wegovy to see if they prevent muscle loss, a problem that drugmakers including Eli Lilly & Co. have been racing to solve.
The analysis examined financial relationships between industry and 92 U.S.-based physicians who helped assemble a recent revision of the Diagnostic and Statistical Manual of Mental Disorders.
GSK is buying biopharmaceutical company Aiolos Bio for up to $1.4 billion in a deal that expands its respiratory pipeline and follows a string of pharmaceutical majors buying fast-growing biotechs.